Equities

Genus PLC

GNS:LSE

Genus PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)3,035.00
  • Today's Change5.00 / 0.17%
  • Shares traded66.48k
  • 1 Year change67.31%
  • Beta1.3893
Data delayed at least 20 minutes, as of Feb 06 2026 16:35 GMT.
More ▼

Profile data is unavailable for this security.

About the company

Genus plc is a United Kingdom-based global animal genetics company. The Company is advancing animal breeding and genetic improvement by applying biotechnology and selling added value products to livestock farming and food producers. It focuses on the dairy, beef and pork food production sectors, through two businesses: ABS (bovine genetics) and PIC (porcine genetics). Its segments include Genus PIC, Genus ABS and Genus Research and Development. Its bovine genetics business sells dairy and beef bull semen and embryos from its superior cattle, which are sold to farmers to breed their cows through artificial insemination. Its porcine genetics business sells genetically superior breeding pigs and semen to farmers, so they can breed commercial pigs with desirable characteristics for pork production. Its porcine and bovine divisions operate under the brand names PIC and ABS. It operates in 30 countries, across six continents, and reaches a further 50 markets through distribution partners.

  • Revenue in GBP (TTM)672.80m
  • Net income in GBP19.30m
  • Incorporated1994
  • Employees3.17k
  • Location
    Genus PLCMatrix House, Basing ViewBASINGSTOKE RG21 4DZUnited KingdomGBR
  • Phone+44 12 5634 7100Fax+44 12 5647 7385
  • Websitehttps://www.genusplc.com
More ▼

Peer analysis

CompanyRevenue (TTM)Net income (TTM)Market capEmployeesMarket Cap /
Employees
Galapagos NV249.77m-386.41m1.64bn558.001.64bn558.00
BioArctic AB156.35m81.56m1.85bn122.001.85bn122.00
Genus plc672.80m19.30m2.02bn3.17k2.02bn3.17k
BB BIOTECH AG498.48m157.74m2.46bn86.002.46bn86.00
Data as of Feb 06 2026. Currency figures normalised to Genus PLC's reporting currency: UK Pound GBX

Institutional shareholders

38.27%Per cent of shares held by top holders
HolderShares% Held
Baillie Gifford & Co.as of 13 Oct 20253.32m4.99%
JNE Partners LLPas of 29 Aug 20253.23m4.86%
Wellington Management Co. LLPas of 29 Aug 20253.22m4.85%
BlackRock Fund Advisorsas of 29 Aug 20252.81m4.23%
Devon Equity Management Ltd.as of 29 Aug 20252.61m3.92%
abrdn Investments Ltd.as of 29 Aug 20252.51m3.77%
BlackRock Investment Management (UK) Ltd.as of 01 Jan 20262.03m3.06%
Capital Research & Management Co. (World Investors)as of 29 Aug 20251.99m2.99%
Threadneedle Asset Management Ltd.as of 29 May 20241.94m2.92%
M&G Investment Management Ltd.as of 01 Jan 20261.79m2.69%
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.